Search Results 201-210 of 17539 for Liposome

  1. https://www.mayoclinic.org/chinese_organization_concepts.xml

  2. A Study to Validate Patient-Reported Outcome Instruments in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection - Mayo Clinic

    - Prior exposure to amikacin liposome inhalation suspension (ALIS) (including clinical study) - Known hypersensitivity or contraindications to use to ALIS ...

  3. Clinical trials - Oncology (Medical)

    Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.

  4. Clinical trials - Oncology (Medical)

    Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.

  5. Clinical trials - Oncology (Medical)

    Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.

  6. Elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (oral route) - Side effects & dosage - Mayo Clinic

    Crizotinib; Dihydroergotamine; Doxorubicin; Doxorubicin Hydrochloride Liposome; Dronedarone; Drospirenone; Eletriptan; Eplerenone; Ergoloid Mesylates ...

  7. Obstetrics and Gynecology - Clinical trials

    ... liposomal doxorubicin \[PLD\]), referred to as "combination drugs'. The study is looking at several other research questions, including: * What side effects ...

  8. Drugs and Supplements that Start with O - Mayo Clinic

    Irinotecan liposome (intravenous route). Onmel. Also known as. Itraconazole (oral route). Onpattro. Also known as. Patisiran (intravenous route). Onsolis. Also ...

  9. Trastuzumab-anns (intravenous route) - Side effects & uses - Mayo Clinic

    Daunorubicin Citrate Liposome; Daunorubicin Liposome; Doxorubicin; Doxorubicin Hydrochloride Liposome; Ebola Zaire Vaccine, Live; Epirubicin; Idarubicin ...

  10. Clinical trials - Oncology (Medical)

    Oncolytic Adenovirus Coding For TNFa And IL2 (TILT-123) With Pembrolizumab Or Pembrolizumab And Pegylated Liposomal Doxorubicin As Treatment For Ovarian Cancer.